American Herbal Products Association (AHPA) > News > Alerts

AHPA adopts labeling guidance for fungi products

Guidance becomes effective March 9, 2019

The Board of Trustees of the American Herbal Products Association (AHPA) at its March 9, 2017 meeting authorized issuance of guidance for labeling products that contain fungi ingredients.
AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA and the entire herbal products industry have greatly benefited from their years of dedication and hard work

The American Herbal Products Association (AHPA) presented its 2017 awards to Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals for substantive and positive contributions to the herbal products industry

CRN/ACI Annual Legal, Regulatory and Compliance Forum on Dietary Supplements

In-depth discussions on the myriad legal, regulatory, and compliance obligations that impact business decisions

Jun 26-28, 2017 -- New York City

AHPA expresses support for synthetic cannabinoids being placed into schedule I

AHPA submits comments to DEA

The American Herbal Products Association (AHPA) expressed strong support for the Drug Enforcement Agency (DEA) using its temporary scheduling authority to place synthetic cannabinoids into schedule I in comments submitted to the agency.

IADSA update on international supplement regulations

IADSA December 2016 Newsflash

This issue of the IADSA Newsflash includes an update on the Association of Southeast Asian Nations (ASEAN) Agreement on Regulatory Framework for Health Supplements deadline for implementation, which will be pushed back to March 2023.

FSMA Direct Impacts to Most AHPA Members

Regulatory experts provide a road map to FSMA understanding requirements and compliance

Webinar recorded Dec. 15, 2016. Member cost: $199. Nonmember cost: $499.

FDA Inspections, Warning Letters and Emerging cGMP Compliance Issues

Learn the elements of 21 CFR 111 / current Good Manufacturing Practice (cGMP) regulations that FDA inspections have been focusing on recently

Webinar recorded Dec. 13, 2016. Member cost: $199. Nonmember cost: $499.

AHPA submits comments to FDA on revised NDI draft guidance

Draft NDI guidance fails to achieve FDA's stated goals and is contrary to intent of the law

In comments submitted to the Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) expressed concern that the latest revision of draft guidance for New Dietary Ingredients (NDIs) is unlikely to achieve FDA's stated goals and is contrary to the intent of the law in numerous areas.

AHPA submits comments to DEA on potential impacts of scheduling herbal constituents

DEA should avoid restricting research on new medical uses, health benefits, or other uses for botanicals

In comments submitted last week to the Drug Enforcement Agency (DEA), the American Herbal Products Association (AHPA) urged the agency to refrain from using its authority to effectively remove a plant from the existing marketplace because naturally occurring constituents become scheduled under the Controlled Substances Act (CSA).

AHPA submits comments to FTC regarding consumer perceptions of "organic" claims

Many personal care products and dietary supplements are produced in compliance with USDA's National Organic Progam

AHPA stressed that non-food products, including personal care products, may be agricultural products that can comply with the United States Department of Agriculture (USDA) National Organic Program (NOP).
RSS
12345678910 Last

 Looking for Something?

 Click on these links to see a filtered list of alerts in one of these four topic areas

 

 


2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.